Consumers blaming weight-loss jabs for eye strokes, ruptured colons and vomiting spells have launched a series of lawsuits against some of the world’s biggest drug manufacturers.
Increasing numbers of Americans turn to GLP-1 drugs in a bid to shed excess weight, with as much as 12 percent of the U.S. now using a weight-loss jab, according to KFF estimates.
